ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

Merritt To Head Nursing Center’s Implementation; Nurse Research And Training Opportunities Varied

January 10, 1986

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

In Brief – Control Of Many Cancer Forms By End Of The Century, Frederickson Tells House Committee

April 6, 1979

In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970

June 1, 1975